Evidence map›Paper›PMID 35349673›Full record

ArticleThe Journal of clinical endocrinology and metabolism2022

Early Warning of Ischemic Stroke Based on Atherosclerosis Index Combined With Serum Markers.

Wenjie Zhou, Shanze Li, Guijiang Sun, Lili Song, Wenjun Feng, Rui Li, Hui Liu, Yaqian Dong, Siyu Chen, Shenshen Yang and 2 more

Abstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Wenjie ZhouState Key Laboratory of Component Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tuanbo New City, Jinghai District, Tianjin 301617, China.
Shanze LiState Key Laboratory of Component Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tuanbo New City, Jinghai District, Tianjin 301617, China.
Guijiang SunDepartment of Kidney Disease and Blood Purification, Tianjin Institute of Urology, Tianjin Medical University Second Hospital, Hexi District, Tianjin 300211, China.
Lili SongState Key Laboratory of Component Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tuanbo New City, Jinghai District, Tianjin 301617, China.
Wenjun FengDepartment of Neurology, Tianjin Medical University Second Hospital, Hexi District, Tianjin 300211, China.
Rui LiState Key Laboratory of Component Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tuanbo New City, Jinghai District, Tianjin 301617, China.
Hui LiuState Key Laboratory of Component Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tuanbo New City, Jinghai District, Tianjin 301617, China.
Yaqian DongState Key Laboratory of Component Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tuanbo New City, Jinghai District, Tianjin 301617, China.
Siyu ChenState Key Laboratory of Component Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tuanbo New City, Jinghai District, Tianjin 301617, China.
Shenshen YangState Key Laboratory of Component Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tuanbo New City, Jinghai District, Tianjin 301617, China.ORCID 0000-0001-5245-9348
Jing LiFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, 88 Changling Road, Xiqing District, Tianjin, Tianjin 300381, China.ORCID 0000-0003-0961-0932
Yubo LiState Key Laboratory of Component Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tuanbo New City, Jinghai District, Tianjin 301617, China.ORCID 0000-0003-0455-0969

Funding

High-level Innovation Team of Tianjin Special Development Support Program-MetabolomicsNew Drug Discovery of Traditional Chinese Medicine KZ1901Science and Technology Talent Cultivation Project of Tianjin Municipal Health Commission KJ20053
6 · The paper itself

Abstract

contextIschemic stroke (IS) is a serious public health problem worldwide, threatening human life and health. Atherosclerosis is the cause of stroke. At present, there are few selective indexes that can be used to evaluate atherosclerosis in the clinic; providers rely mainly on the atherosclerotic index (AI). Disturbance of lipid metabolism is considered to be a key event leading to IS.

objectiveThe purpose of this study was to discover potential biomarkers in the serum of atherosclerosis-induced IS, combined with the AI to provide early warning for the diagnosis of IS.

methodsIn this study, we used nontargeted metabolomics based on ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-Q/TOF-MS) to measure the changes in serum metabolites in a group of patients with IS. To verify the reproducibility of candidate biomarkers in the population, we expanded the sample size.

resultsFive metabolites were identified, including sphingomyelin (18:0/14:0), 1-Methylpyrrolinium, PC (18:0/18:0), LysoPC (18:0/0:0), and PC (18: 2/18:2). The combination of these 5 metabolic markers has good diagnostic and predictive ability, and the change level of these metabolites is significantly related to IS. Our results also indicate that changes in glycerophospholipid metabolism may indicate an early risk of IS development.

conclusionThese findings may contribute to the development of new diagnostic methods of potential biomarkers in serum combined with the AI, thereby providing early warning for the diagnosis of atherosclerosis-induced IS, and may provide a new insights for pathogenesis in IS.

Indexed as

AtherosclerosisIschemic StrokeBiomarkersChromatography, High Pressure LiquidHumansMetabolomicsReproducibility of ResultsBiomarkersatherosclerosis Indexbiomarkerischemic strokemetabolomicsserumUPLC-Q-TOF/MS

Identifiers

PMID35349673
PMCPMC9202721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.